EUVIMEDEUVIMED entdecken
Open Access

HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumors

Daniel Hwang iD, Molly C Erdman iD, Santosh Adhikari, Ram Pantula, Kaya Epstein iD, Peiyao Li iD, Francesca Costabile, Photis Rotsides iD, Chloe S Wang iD, Shirley M Sun iD, Hossein Fazelinia, Lynn A Spruce iD und 9 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.aeb0821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Daniel Hwang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA…. Hauptthemen laut MEDLINE: Antigen Presentation, Histocompatibility Antigens Class I, HLA Antigens, Neuroblastoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epitopic peptides presented by class-I human leukocyte antigen (HLA-I) proteins provide the basis of immune surveillance by T cells. Conversely, reduced surface HLA-I expression is a hallmark of immune evasion by latent viral infections and cancer, which confounds the identification of peptide antigens and neoantigens. Here, we outline a system (HLA-Shuttle) for in vitro manipulation of cells with engineered components of the HLA-I processing machinery to confer a continuum of chaperoning activity throughout their trafficking pathway. HLA-Shuttle restores antigen presentation in immunologically cold neuroblastoma cells, enabling identification of multiple tumor-associated antigens with therapeutic potential. Cellular trafficking assays and single-particle tracking reveal a global stabilization of HLA-I molecules, extension of their cell-surface lifetime and microdomain formation. HLA-Shuttle can be used across a range of aberrant cellular states where low antigen expression remains a bottleneck for the identification of endogenous peptide antigens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigen PresentationHistocompatibility Antigens Class IHLA AntigensNeuroblastomaHumansAntigens, NeoplasmCell Line, TumorPeptides

Substanzen

Antigens, NeoplasmHistocompatibility Antigens Class IHLA AntigensPeptides

Autor:innen und Institutionen

  • Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Howard Hughes Medical Institute and Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Cancer Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

ORCID-Profile: Daniel Hwang, Molly C Erdman, Kaya Epstein, Peiyao Li, Photis Rotsides, Chloe S Wang, Shirley M Sun, Lynn A Spruce, Tim Fugmann, Trendelina Rrustemi, Wai Tuck Soh, Alvin Farrel, Andrea Facciabene, Mustafa Mir, John M Maris, Nikolaos G Sgourakis

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • National Institute of General Medical Sciences
  • National Institute of Allergy and Infectious Diseases
  • Cancer Research UK

Zitieren

APA

Hwang, D., Erdman, M. C., Adhikari, S., Pantula, R., Epstein, K., Li, P., Costabile, F., Rotsides, P., Wang, C. S., Sun, S. M., Fazelinia, H., Spruce, L. A., Fugmann, T., Rrustemi, T., Soh, W. T., Farrel, A., Want, M. Y., Facciabene, A., Mir, M., …, & Sgourakis, N. G. (2026). HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumors. Science Advances. https://doi.org/10.1126/sciadv.aeb0821

Vancouver

Hwang D, Erdman MC, Adhikari S, Pantula R, Epstein K, Li P, et al. HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumors. Science Advances. 2026. doi:10.1126/sciadv.aeb0821

BibTeX
@article{Hwang2026,
  author = {Hwang, Daniel and Erdman, Molly C and Adhikari, Santosh and Pantula, Ram and Epstein, Kaya and Li, Peiyao and Costabile, Francesca and Rotsides, Photis and Wang, Chloe S and Sun, Shirley M and Fazelinia, Hossein and Spruce, Lynn A and Fugmann, Tim and Rrustemi, Trendelina and Soh, Wai Tuck and Farrel, Alvin and Want, Muzamil Y and Facciabene, Andrea and Mir, Mustafa and Maris, John M and Sgourakis, Nikolaos G},
  title = {HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumors},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aeb0821}
}
Kostenlos starten →